izpis_h1_title_alt

Stability of reduced and oxidized coenzyme Q10 in finished products
ID Temova Rakuša, Žane (Avtor), ID Kristl, Albin (Avtor), ID Roškar, Robert (Avtor)

.pdfPDF - Predstavitvena datoteka, prenos (1,45 MB)
MD5: 79DB476869FB226BC0470D51868EF7BD
URLURL - Izvorni URL, za dostop obiščite https://www.mdpi.com/2076-3921/10/3/360 Povezava se odpre v novem oknu

Izvleček
The efficiency of coenzyme Q10 (CoQ10) supplements is closely associated with its content and stability in finished products. This study aimed to provide evidence-based information on the quality and stability of CoQ10 in dietary supplements and medicines. Therefore, ubiquinol, ubiquinone, and total CoQ10 contents were determined by a validated HPLC-UV method in 11 commercial products with defined or undefined CoQ10 form. Both forms were detected in almost all tested products, resulting in a total of CoQ10 content between 82% and 166% of the declared. Ubiquinol, ubiquinone, and total CoQ10 stability in these products were evaluated within three months of accelerated stability testing. Ubiquinol, which is recognized as the less stable form, was properly stabilized. Contrarily, ubiquinone degradation and/or reduction were observed during storage in almost all tested products. These reactions were also detected at ambient temperature within the products shelf-lives and confirmed in ubiquinone standard solutions. Ubiquinol, generated by ubiquinone reduction with vitamin C during soft-shell capsules storage, may lead to higher bioavailability and health outcomes. However, such conversion and inappropriate content in products, which specify ubiquinone, are unacceptable in terms of regulation. Therefore, proper CoQ10 stabilization through final formulations regardless of the used CoQ10 form is needed.

Jezik:Angleški jezik
Ključne besede:assay, coenzyme Q10 content, commercial products, dietary supplements, HPLC-UV, medicines, reducing agent, stability, ubiquinol, ubiquinone
Vrsta gradiva:Članek v reviji
Tipologija:1.01 - Izvirni znanstveni članek
Organizacija:FFA - Fakulteta za farmacijo
Status publikacije:Objavljeno
Različica publikacije:Objavljena publikacija
Leto izida:2021
Št. strani:17 str.
Številčenje:Vol. 10, iss. 3, art. 360
PID:20.500.12556/RUL-135060 Povezava se odpre v novem oknu
UDK:577.161.6:613.292
ISSN pri članku:2076-3921
DOI:10.3390/antiox10030360 Povezava se odpre v novem oknu
COBISS.SI-ID:53472259 Povezava se odpre v novem oknu
Datum objave v RUL:18.02.2022
Število ogledov:1283
Število prenosov:146
Metapodatki:XML RDF-CHPDL DC-XML DC-RDF
:
Kopiraj citat
Objavi na:Bookmark and Share

Gradivo je del revije

Naslov:Antioxidants
Skrajšan naslov:Antioxidants
Založnik:MDPI
ISSN:2076-3921
COBISS.SI-ID:522976025 Povezava se odpre v novem oknu

Licence

Licenca:CC BY 4.0, Creative Commons Priznanje avtorstva 4.0 Mednarodna
Povezava:http://creativecommons.org/licenses/by/4.0/deed.sl
Opis:To je standardna licenca Creative Commons, ki daje uporabnikom največ možnosti za nadaljnjo uporabo dela, pri čemer morajo navesti avtorja.

Sekundarni jezik

Jezik:Slovenski jezik
Ključne besede:koencim 10, stabilnost učinkovin, ubikinon, prehranska dopolnila

Projekti

Financer:ARRS - Agencija za raziskovalno dejavnost Republike Slovenije
Številka projekta:P1-0189
Naslov:Farmacevtska tehnologija: od dostavnih sistemov učinkovin do terapijskih izidov zdravil pri otrocih in starostnikih

Podobna dela

Podobna dela v RUL:
Podobna dela v drugih slovenskih zbirkah:

Nazaj